UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000028939
Receipt No. R000032932
Official scientific title of the study Causative bacteria and the clinical course in eyes underwent vitrectomy for acute endophthalmitis after intravitreal injection
Date of disclosure of the study information 2017/08/31
Last modified on 2017/08/31 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Causative bacteria and the clinical course in eyes underwent vitrectomy for acute endophthalmitis after intravitreal injection
Title of the study (Brief title) Causative bacteria of acute endophthalmitis after intravitreal injection
Region
Japan

Condition
Condition acute endophthalmitis after intravitreal injection
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate visual prognosis and clinical
course ofacute endophthalmitis after intravitreal injection
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes visual prognosis
Key secondary outcomes Species of pathogenic bacteria

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria acute endophthalmitis after intravitreal injection
Key exclusion criteria none
Target sample size 6

Research contact person
Name of lead principal investigator Makoto Inoue
Organization Kyorin University School of Medicine
Division name Department of Ophthalmlology
Address Shinkawa Mitaka Tokyo Japan
TEL 0422-47-5511
Email inoue@eye-center.org

Public contact
Name of contact person Tsukasa Mochizuki
Organization Kyorin University School of Medicine
Division name Department of Ophthalmlology
Address Shinkawa, Mitaka, Tokyo, Japan
TEL 0422-47-5511
Homepage URL
Email mochizuki@eye-center.org

Sponsor
Institute Kyorin University School of Medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 08 Month 31 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2017 Year 06 Month 15 Day
Anticipated trial start date
2017 Year 07 Month 12 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information From April 2010 to March 2017, we investigated cases of vitreous surgery for endophthalmitis after intravitreal injection of anti-VEGF drugs from the medical record . We also examined the incidence of endophthalmitis after intravitreal injection based on the number of intravitreal injections of anti - VEGF drugs within the same period.

Management information
Registered date
2017 Year 08 Month 31 Day
Last modified on
2017 Year 08 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032932